Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2:30 PM<br />
2:45 PM<br />
3:00 PM<br />
<strong>Program</strong><br />
Imaging II<br />
Clinical Implications of Imaging and<br />
Physiology Tools<br />
Moderators: Takashi Akasaka<br />
Patrick W. Serruys<br />
3:48 PM<br />
4:00 PM<br />
4:12 PM<br />
Linkage of Current Plaque<br />
Vulnerability to Future Events:<br />
Evidence from PROSPECT Study<br />
Gregg W. Stone<br />
Current OCT Plaque<br />
Vulnerability: The Past Is the<br />
Mirror of Future?<br />
Ik-Kyung Jang<br />
Future in Vulnerable Plaque Imaging<br />
Ron Waksman<br />
Abstract Presentation<br />
3:15 PM<br />
3:27 PM<br />
3:39 PM<br />
AS-27, Plaque Characteristics in<br />
Culprit Lesions in Diabetic Acute<br />
Coronary Syndrome Patients:<br />
Intravascular Ultrasound and<br />
Virtual Histology-Intravascular<br />
Ultrasound Analysis<br />
Young Joon Hong<br />
AS-23, Comparison of<br />
Subsequent Vascular Response<br />
in Diabetic Patients after<br />
Coronary Stenting between<br />
Sirolimus- and Paclitaxel-Eluting<br />
Stents: Optical Coherence<br />
Tomography Analysis<br />
Kenya Nasu<br />
Moderated Discussion with<br />
Audience Q & A<br />
Current and Future Role of IVUS,<br />
VH-IVUS, and OCT Role in PCI<br />
Patients<br />
Gulio Guagliumi<br />
OCT and Vascular Healing<br />
Following DES Implantation:<br />
Insights form Histology<br />
Juan Granada<br />
Endothelial Dysfunction<br />
Associated with DES: How<br />
Important?<br />
Alan C. Yeung<br />
4:24 PM<br />
4:36 PM<br />
4:48 PM<br />
5:00 PM<br />
5:12 PM<br />
Current and Future Role of<br />
CT/MRI Imaging for Screening<br />
Asymptomatic CAD and<br />
Triaging ACS Patients<br />
James K. Min<br />
On-Line 4D CT Reconstruction<br />
for Planning and Executing<br />
Complex Structural Heart<br />
Disease Intervention<br />
Howard A. Cohen<br />
SPECT and PET Imaging: How<br />
Useful for PCI Patients<br />
Won-Jun Kang<br />
Vulnerable Plaque Trials Using<br />
Surrogate Imaging Marker<br />
Patrick W. Serruys<br />
Percutaneous Therapy of<br />
Structural Heart Disease<br />
Using Imaging Modality<br />
Ted Feldman<br />
Debate : Imaging Modality for Detection of<br />
Vulnerable Plaque<br />
5:24 PM<br />
5:36 PM<br />
5:48 PM<br />
6:00 PM<br />
Invasive Imaging Is Certainly<br />
More Accurate !<br />
Takashi Akasaka<br />
Non-Invasive Imaging Is More<br />
Clinically Relevant!<br />
James K. Min<br />
Discussion<br />
Adjourn<br />
Tutorial Arena<br />
8:30 AM-5:45 PM<br />
How to Make Good Clinical Trials<br />
"Clinical Trial Design and Medical<br />
Statistics: A Symposium for Researchers"<br />
Clinical Trial Core Concepts<br />
Moderators: Roxana Mehran<br />
Young-Hak Kim<br />
Discussants: Heather Agler<br />
David J. Cohen<br />
Donald E. Cutlip<br />
Helen Parise<br />
8:30 AM<br />
8:45 AM<br />
9:00 AM<br />
9:15 AM<br />
9:30 AM<br />
9:45 AM<br />
Randomized Trials vs.<br />
Observational Registries:<br />
Strengths and Weaknesses<br />
David J. Cohen<br />
Utility and Pitfalls of Composite<br />
and Surrogate Endpoints in<br />
Clinical Trials<br />
Helen Parise<br />
Quality Control of Clinical<br />
Trials: Blinding, Clinical Event<br />
Committees, Core Labs, and<br />
Data Standards<br />
Roxana Mehran<br />
Responsibilities of Investigators<br />
in Clinical Trials: From Consent<br />
to Safety Reporting<br />
Young-Hak Kim<br />
Regulatory Perspectives of<br />
Clinical Trials: What Core<br />
Elements does FDA Look for?<br />
Heather Agler<br />
Moderated Roundtable<br />
Discussion with Audience Q&A<br />
A Primer of Medical Statistics<br />
Moderators: David J. Cohen<br />
Roxana Mehran<br />
Discussants: Heather Agler<br />
Donald E. Cutlip<br />
Young-Hak Kim<br />
Helen Parise<br />
10:05 AM<br />
10:20 AM<br />
10:40 AM<br />
11:00 AM<br />
Medical Statistics 101: Basic<br />
Comparative Statistics,<br />
Parametric and Non<br />
Parametric P Values and<br />
Confidence Intervals, Trial Size<br />
Donald E. Cutlip<br />
The Nuances of Superiority and<br />
Non-Inferiority Trials: Design<br />
Considerations, Choice of<br />
Endpoints, Cost Effectiveness<br />
Analyses<br />
David J. Cohen<br />
Moderated Roundtable<br />
Discussion with Audience Q&A<br />
Adjourn
Change language